Ads
related to: clozapine schizophrenia treatmentsmartholidayshopping.com has been visited by 1M+ users in the past month
Search results
Results from the WOW.Com Content Network
The role of clozapine in treatment-resistant schizophrenia was established by a 1988 landmark multicenter double blind study [40] in which clozapine (up to 900 mg/d) showed marked benefits compared to chlorpromazine (up to 1800 mg/d) in a group of patients with protracted psychosis who had already shown an inadequate response to at least three ...
[149] [150] Clozapine is of benefit to around half of this group although it has the potentially serious side effect of agranulocytosis (lowered white blood cell count) in less than 4% of people. [151] [152] [153] Between 12 and 20 per cent will not respond to clozapine and this group is said to have ultra treatment resistant schizophrenia.
Clozapine is an effective treatment for those who respond poorly to other drugs ("treatment-resistant" or "refractory" schizophrenia), [94] but it has the potentially serious side effect of agranulocytosis (lowered white blood cell count) in less than 4% of people.
Saphris – atypical antipsychotic used to treat schizophrenia and bipolar disorder; Serax – anti-anxiety medication of the benzodiazepine class, often used to help during detoxification from alcohol or other addictive substances; Serentil (mesoridazine) – an antipsychotic drug used in the treatment of schizophrenia [1]
“This drug takes the first new approach to schizophrenia treatment in decades,” said Tiffany Farchione, the director of the Division of Psychiatry, Office of Neuroscience in the FDA’s Center ...
Clozapine is considered a first choice treatment for treatment resistant schizophrenia, especially in the short term; in the longer-terms the risks of adverse effects complicate the choice. [19] In turn, risperidone, olanzapine, and aripiprazole have been recommended for the treatment of first-episode psychosis. [20] [21]
Ads
related to: clozapine schizophrenia treatmentsmartholidayshopping.com has been visited by 1M+ users in the past month